Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Tanaka, Kenichi

One or more keywords matched the following items that are connected to Tanaka, Kenichi

Item Type	Name
Concept	Factor IX
Concept	Factor V
Concept	Factor V Deficiency
Concept	Factor VIII
Concept	Factor X
Concept	Factor VIIa
Concept	Factor IXa
Academic Article	In vitro effects of recombinant activated factor VII on thrombin generation and coagulation following inhibition of platelet procoagulant activity by prasugrel.
Academic Article	In vitro effects of emicizumab on activated clotting time in blood samples from cardiac surgical patients.
Academic Article	Coagulation Management During Liver Transplantation: Use of Fibrinogen Concentrate, Recombinant Activated Factor VII, Prothrombin Complex Concentrate, and Antifibrinolytics.
Academic Article	Perioperative Coagulation Management of a Hemophilia A Patient During Cardiac Surgery.
Academic Article	Reduced Requirement for Prothrombin Complex Concentrate for the Restoration of Thrombin Generation in Plasma From Liver Transplant Recipients.
Academic Article	Roles of Four-Factor Prothrombin Complex Concentrate in the Management of Critical Bleeding.
Academic Article	In-vitro evaluation of anti-factor IXa aptamer on thrombin generation, clotting time, and viscoelastometry.
Academic Article	Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation.
Academic Article	Thromboelastography Reaction-Time Thresholds for Optimal Prediction of Coagulation Factor Deficiency in Trauma.
Academic Article	Optimizing Thrombin Generation with 4-Factor Prothrombin Complex Concentrates in Neonatal Plasma After Cardiopulmonary Bypass.
Academic Article	Ex vivo evaluation of 4 different viscoelastic assays for detecting moderate to severe coagulopathy during liver transplantation.
Academic Article	Three-factor prothrombin complex concentrate and hemostasis after high-risk cardiovascular surgery.
Academic Article	Impact on postoperative bleeding and cost of recombinant activated factor VII in patients undergoing heart transplantation.
Academic Article	Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P).
Academic Article	Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model.
Academic Article	Hemophilia: A Review of Perioperative Management for Cardiac Surgery.
Academic Article	Warfarin reversal with prothrombin complex concentrate confers better antifibrinolytic activity compared with recombinant activated factor VII.
Academic Article	Argatroban "reversal" is caused by nonphysiologic stimulation of coagulation, not activated factor VII.
Academic Article	Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding.
Academic Article	Thresholds for Perioperative Administration of Hemostatic Blood Components and Coagulation Factor Concentrates: An Unmet Medical Need.
Academic Article	Perioperative Management of Hereditary Factor V Deficiency: Timing of Plasma Administration is Critical in Maximizing Hemostatic Potency of Transfused Factor V.
Academic Article	Antithrombin affects hemostatic response to recombinant activated factor VII in factor VIII deficient plasma.
Academic Article	Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest.
Academic Article	Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa.
Academic Article	The anticoagulant effect of protamine sulfate is attenuated in the presence of platelets or elevated factor VIII concentrations.
Academic Article	Prohemostatic Activity of Factor X in Combination With Activated Factor VII in Dilutional Coagulopathy.
Academic Article	Andexanet?alfa or prothrombin complex concentrate for acute reversal of oral factor Xa inhibitors: monitoring of antidote effects.

Search Criteria

Complement Factor B